Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-10 | Mr. John C.M. FarquharPresident, CEO & Director | -22,56k | 643,02k | Automatic Disposition | 28,50 | 496,84k | -4,34% |
| 2026-05-18 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | -9,22k | 86,11k | Derivative Exercise and Sale | 19,00 - 28,34 | 224,27k | - |
| 2026-05-11 | Mr. John C.M. FarquharPresident, CEO & Director | -22,56k | 657,01k | Automatic Disposition | 29,12 | 519,40k | -4,16% |
| 2026-05-06 | Mr. John C.M. FarquharPresident, CEO & Director | -7,20k | 217,62k | Sale to Issuer | 29,98 - 30,29 | 541,96k | -1,31% |
| 2026-04-28 | Bain Capital Life Sciences Investors, LLCUnternehmen | -2,00M | 58,90M | Verkauf | 29,18 - 30,51 | 8,45M | -19,14% |
| 2026-04-10 | Mr. John C.M. FarquharPresident, CEO & Director | -22,56k | 602,86k | Automatic Disposition | 26,72 | 549,16k | -3,95% |
| 2026-04-01 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | -64,53k | 1,45M | Derivative Exercise and Sale | 2,22 - 24,64 | 154,05k | - |
| 2026-04-01 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | 2,48k | 7,29k | Derivative Exercise and Retained Stock | 2,22 - 8,33 | 154,05k | 1,64% |
| 2026-03-24 | HealthCor Management L.P.Unternehmen | -4,62M | 0,00 | Other Disposition | - | 0,00 | -100,00% |
| 2026-03-19 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | -64,53k | 1,51M | Derivative Exercise and Sale | 2,22 - 25,69 | 151,57k | - |
| 2026-03-19 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | 2,48k | 5,51k | Derivative Exercise and Retained Stock | 2,22 | 151,57k | 1,67% |
| 2026-03-18 | Mr. John C.M. FarquharPresident, CEO & Director | -9,73k | 243,13k | Automatic Disposition | 25,00 | 571,73k | -1,67% |
| 2026-03-11 | Mr. Timothy C. BarabeIndependent Director | 8,67k | 19,24k | Derivative Exercise and Retained Stock | 2,22 | 179,52k | 5,07% |
| 2026-03-10 | Mr. John C.M. FarquharPresident, CEO & Director | -12,84k | 290,89k | Verkauf | 22,66 | 236,24k | -5,15% |
| 2026-03-05 | Ms. Julie Anne CullivanIndependent Director | -9,12k | 228,05k | Automatic Disposition | 25,00 | 27,29k | -25,05% |
| 2026-02-17 | Mr. Timothy C. BarabeIndependent Director | 2,50k | 20,80k | Derivative Exercise and Retained Stock | 8,33 | 170,85k | 1,48% |
| 2026-02-12 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | 1,86k | 4,14k | Derivative Exercise and Retained Stock | 2,22 | 149,08k | 1,27% |
| 2026-02-12 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | -65,15k | 1,21M | Derivative Exercise and Sale | 2,22 - 24,49 | 149,08k | - |
| 2026-02-06 | Ms. Mhairi L. JonesInsider | -94,00 | 2,61k | Sale to Issuer | 27,74 | 6,86k | -1,35% |
| 2026-02-10 | Mr. John C.M. FarquharPresident, CEO & Director | -22,56k | 619,55k | Automatic Disposition | 27,46 | 355,42k | -5,97% |
| 2026-02-06 | Mr. John C.M. FarquharPresident, CEO & Director | -1,54k | 42,75k | Sale to Issuer | 27,74 | 355,42k | -0,43% |
| 2026-02-06 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | -515,00 | 14,29k | Sale to Issuer | 27,74 | 147,22k | -0,35% |
| 2026-02-06 | Mr. Vikram VergheseCFO | -542,00 | 15,04k | Sale to Issuer | 27,74 | 125,95k | -0,43% |
| 2026-02-05 | Ms. Julie Anne CullivanIndependent Director | -8,00k | 218,56k | Automatic Disposition | 27,32 | 36,41k | -18,01% |
| 2026-02-04 | Bain Capital Life Sciences Investors, LLCUnternehmen | -2,00M | 56,10M | Verkauf | 28,05 | 10,45M | -16,07% |
| 2025-12-16 | HealthCor Management L.P.Unternehmen | 40,00k | 1,05M | Kauf | 26,34 | 6,74M | 0,60% |
| 2025-11-07 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | -439,00 | 14,29k | Sale to Issuer | 32,56 | 146,42k | -0,30% |
| 2025-11-07 | Mr. John C.M. FarquharPresident, CEO & Director | -1,34k | 43,60k | Sale to Issuer | 32,56 | 375,78k | -0,36% |
| 2025-11-07 | Mr. Vikram VergheseCFO | -471,00 | 15,34k | Sale to Issuer | 32,56 | 125,18k | -0,37% |
| 2025-11-07 | Ms. Mhairi L. JonesInsider | -81,00 | 2,64k | Sale to Issuer | 32,56 | 6,72k | -1,19% |
| 2025-08-11 | Bain Capital Life Sciences Investors, LLCUnternehmen | 12,45M | 6,60M | Derivative Exercise and Retained Stock | 15,20 | 12,45M | - |
| 2025-08-11 | Mr. William C. WeldonIndependent Chairman of the Board | 136,29k | 0,00 | Derivative Exercise and Retained Stock | - | 192,56k | 242,17% |
| 2025-08-11 | Mr. Timothy C. BarabeIndependent Director | 131,58k | 0,00 | Derivative Exercise and Retained Stock | - | 168,36k | 357,75% |
| 2025-08-11 | USVP Management Company, LLCUnternehmen | 3,19M | 0,00 | Derivative Exercise and Retained Stock | - | 3,19M | - |
| 2025-08-11 | Ms. Mhairi L. JonesInsider | 6,58k | 0,00 | Derivative Exercise and Retained Stock | - | 6,58k | - |
| 2025-08-11 | Mr. Vikram VergheseCFO | 9,52k | 0,00 | Derivative Exercise and Retained Stock | - | 124,33k | 8,29% |
| 2025-08-11 | HealthCor Management L.P.Unternehmen | 6,70M | 0,00 | Derivative Exercise and Retained Stock | - | 6,70M | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
